Evommune, Inc. (EVMN) Revenue 2024–2025
Evommune, Inc. (EVMN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$13.0MFY2025 · since FY2024: $7.0M → $13.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.0M | +85.7% |
| FY2024 | $7.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EVMN financial trends
EVMN Net incomeEVMN Net marginEVMN Gross profitEVMN Gross marginEVMN Operating incomeEVMN Operating marginEVMN Operating cash flowEVMN Free cash flowEVMN Capital expendituresEVMN Return on equityEVMN Stock buybacksEVMN Dividends paidEVMN Total assetsEVMN Total liabilitiesEVMN Shareholders’ equityEVMN overview →